An update on larynx cancer

CE Steuer, M El‐Deiry, JR Parks… - CA: a cancer journal …, 2017 - Wiley Online Library
Answer questions and earn CME/CNE Laryngeal cancer remains one of the most common
tumors of the respiratory tract. Fortunately, significant advancements have been made over …

Expert consensus document on pulmonary metastasectomy

JR Handy, RM Bremner… - The Annals of …, 2019 - annalsthoracicsurgery.org
17. When managing NSGCTs, PM is indicated for select patients with limited number of lung
abnormalities after first-line or second-line platin-based chemotherapy suspected of …

Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy …

JE Leeman, J Li, X Pei, P Venigalla, ZS Zumsteg… - JAMA …, 2017 - jamanetwork.com
Importance Even though 15% to 50% of patients with head and neck squamous cell
carcinoma (HNSCC) experience recurrence, relatively little is known regarding patterns of …

Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges.

TM Wise-Draper, H Bahig, M Tonneau… - American Society of …, 2022 - europepmc.org
Management of metastatic head and neck squamous cell carcinoma is evolving as new
systemic therapies have led to improvements in survival, and as advances in locoregional …

Recurrent/metastatic squamous cell carcinoma of the head and neck: a big and intriguing challenge which may be resolved by integrated treatments combining …

F Ionna, P Bossi, A Guida, A Alberti, P Muto, G Salzano… - Cancers, 2021 - mdpi.com
Simple Summary The purpose of this manuscript is to illustrate the difficulties associated
with the treatment of the patient with recurrent metastatic SCCHN. This type of patient is very …

Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence

AS Ho, GJ Tsao, FW Chen, T Shen, MJ Kaplan… - Cancer, 2013 - Wiley Online Library
BACKGROUND: In head and neck cancer (HNC), 3‐month post‐treatment positron emission
tomography (PET)/computed tomography (CT) reliably identifies persistent/recurrent …

The past, present and future of pulmonary metastasectomy: a review article

FPY Cheung, NZ Alam, GM Wright - Annals of Thoracic and …, 2019 - jstage.jst.go.jp
Pulmonary metastases are a sign of advanced malignancy and an omen of poor prognosis.
Once primary tumors metastasize, they become notoriously difficult to treat and …

[HTML][HTML] Pulmonary metastasectomy: an overview

F Petrella, C Diotti, A Rimessi… - Journal of thoracic …, 2017 - ncbi.nlm.nih.gov
Metastasectomy is the most frequent surgical resection undertaken by thoracic surgeons,
being the lung the second common site of metastases. The present oncological criteria for …

The role of local therapy in the management of lung and liver oligometastases

SS Lo, SD Moffatt-Bruce, LA Dawson… - Nature reviews Clinical …, 2011 - nature.com
Despite recent advances in oncologic therapy, an important proportion of patients with
primary cancer will develop distant metastasis. The standard therapy for metastatic cancer is …

Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta‐analysis

ER Young, E Diakos, M Khalid‐Raja… - Clinical …, 2015 - Wiley Online Library
Background Pulmonary metastasectomy involves the surgical removal of pulmonary
nodules. It is a recognised therapeutic modality for the treatment of metastatic disease …